Works matching IS 02698811 AND DT 2004 AND VI 18 AND IP 3

Results: 21

Changes in pharmacological treatment for bipolar disorder over time in Manchester: a comparison with Lloyd et al. (2003).

Published in:

2004

By:

Anderson, Ian M.;
Haddad, Peter M.;
Chaudhry, Imran

Publication type:

research

Magnesium homeostasis and antipsychotic-induced QTc prolongation.

Published in:

2004

By:

Meenagh, Ciaran;
Mulholland, Ciaran;
Ryan, Michael F.

Publication type:

Letter

Effects of reboxetine on sleep and nocturnal cardiac autonomic activity in patients with dysthymia.

Published in:

Journal of Psychopharmacology, 2004, v. 18, n. 3, p. 417, doi. 10.1177/026988110401800313

By:

Ferini-Strambi, Luigi;
Manconi, Mauro;
Castronovo, Vincenza;
Riva, Laura;
Bianchi, Anna

Publication type:

Article

Vigabatrin and tiaggabine might have antipanic properties.

Published in:

2004

By:

Zwanger, P.;
Rupprecht, R.

Publication type:

Letter

Rhabdomyolysis and compartment syndrome with coadministration of risperidone and simvastatin.

Published in:

2004

By:

Webber, Michael A.;
Mahmud, Waqar;
Lightfoot, Jeffery D.;
Shekhar, Anantha

Publication type:

Case Study

The effects of clozapine and high-dose olanzapine on brain function in treatment-resistant schizophrenia: a case study.

Published in:

2004

By:

Conley, Robert R.;
Kelly, Deanna C.;
Beason-Held, Lori L.;
Holcomb, Henry H.;
Richardson, Charles M.;
Kelly, Deanna L

Publication type:

journal article

Use of reboxetine in bulimia nervosa: a pilot study.

Published in:

Journal of Psychopharmacology, 2004, v. 18, n. 3, p. 423, doi. 10.1177/026988110401800314

By:

Fassino, Secondo;
Daga, Giovanni Abbate;
Boggio, Sonia;
Garzaro, Lorenzo;
Pierò, Andrea

Publication type:

Article

Diabetic keto-acidotic (DKA) coma following olanzapine initiation in a previously euglycaemic woman and successful continued therapy with olanzapine.

Published in:

2004

By:

Howes, O. D.;
Rifkin, L.

Publication type:

journal article

Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurons.

Published in:

Journal of Psychopharmacology, 2004, v. 18, n. 3, p. 412, doi. 10.1177/026988110401800312

By:

Sanchez, Veronica;
O'Shea, Esther;
Saadat, Kathryn S.;
Elliott, J. Martin;
Colado, N. Isabel;
Green, A. Richard

Publication type:

Article

Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: comparative study with desipramine, fluvoxamine, venlafaxine and opiates.

Published in:

Journal of Psychopharmacology, 2004, v. 18, n. 3, p. 405, doi. 10.1177/026988110401800305

By:

Rojas-Corrales, M. Olga;
Berrocoso, Esther;
Gibert-Rahola, Juan;
Mic&oacute, Juan Antonio

Publication type:

Article

The role of α1- and α2-adrenoreceptors on venlafaxine-induced elevation of extracellular serotonin, noradrenaline and dopamine levels in the rat prefrontal cortex and hippocampus.

Published in:

Journal of Psychopharmacology, 2004, v. 18, n. 3, p. 395, doi. 10.1177/026988110401800311

By:

Weikop, P.;
Kehr, J.;
Scheet-Krüger, J.

Publication type:

Article

Increasing dopaminergic activity: effects of L-dopa and bromocriptine on human sensory gating.

Published in:

Journal of Psychopharmacology, 2004, v. 18, n. 3, p. 388, doi. 10.1177/026988110401800310

By:

Oranje, B.;
Gispen-de Weid, C. C.;
Westenberg, H. G. M.;
Kemner, C.;
Verbaten, M. N.;
Kahn, R. S.

Publication type:

Article

No association between akathisia or Parkinsonism and suicidality in treatment-resistant Schizophrenia.

Published in:

2004

By:

Hansen, Lars;
Jones, Roland Morgan;
Kingdon, David

Publication type:

journal article

Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile.

Published in:

2004

By:

Hirose, Tsuyoshi;
Uwahodo, Yasufumi;
Yamada, Sakiko;
Miwa, Takashi;
Kikuchi, Tetsuro;
Kitagawa, Hisashi;
Burris, Kevin D.;
Altar, C. Anthony;
Nabeshima, Toshitaka

Publication type:

journal article

The relationship of sex hormones cortisol with cognitive functioning in schizophrenia.

Published in:

Journal of Psychopharmacology, 2004, v. 18, n. 3, p. 366, doi. 10.1177/026988110401800307

By:

Halari, R.;
Kumari, V.;
Mehrotra, R.;
Wheeler, M.;
Hines, M.;
Sharma, T.

Publication type:

Article

Cerebral D2 and 5-HT2 receptor occupancy in Schizophrenic patients treated with olanzapine or clozapine.

Published in:

2004

By:

Moresco, Rosa Maria;
Cavallaro, Roberto;
Messa, Cristina;
Bravi, Daniele;
Gobbo, Clara;
Galli, Laura;
Lucignani, Giovanni;
Colombo, Cristina;
Rizzo, Giovanna;
Verona, Isabella;
Smeraldi, Enrico;
Fazio, Ferruccio;
Velonà, Isabella

Publication type:

journal article

A positron emission tomography study of the 5-HT1A receptor in schizophrenia and during clozapine treatment.

Published in:

Journal of Psychopharmacology, 2004, v. 18, n. 3, p. 347, doi. 10.1177/026988110401800304

By:

Bantick, R. Alexander;
Montgomery, Andrew J.;
Bench, Christopher J.;
Choudhry, Tariq;
Malek, Nina;
McKenna, Peter J.;
Quested, Digby J.;
Deakin, J.F. William;
Grasby, Paul M.

Publication type:

Article

Receptor mechanisms in the treatment of schizophrenia.

Published in:

Journal of Psychopharmacology, 2004, v. 18, n. 3, p. 340, doi. 10.1177/026988110401800303

By:

Reynolds, Gavin P.

Publication type:

Article

Gender differences and the effects of ketamine healthy volunteers.

Published in:

Journal of Psychopharmacology, 2004, v. 18, n. 3, p. 337, doi. 10.1177/026988110401800302

By:

Lees, Jane;
Hattak, Jaime E. C.;
Deakin, John F. W.;
Dursun, Serdar M.

Publication type:

Article

Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for Psychopharmacology.

Published in:

Journal of Psychopharmacology, 2004, v. 18, n. 3, p. 293, doi. 10.1177/026988110401800321

By:

Lingford-Hughes, A. R.;
Welch, S.;
Nutt, D. J.

Publication type:

Article

An exceptional case of plagiarism!

Published in:

2004

By:

Bailey, Jayne E.

Publication type:

Editorial

Works matching IS 02698811 AND DT 2004 AND VI 18 AND IP 3

Changes in pharmacological treatment for bipolar disorder over time in Manchester: a comparison with Lloyd et al. (2003).

Magnesium homeostasis and antipsychotic-induced QTc prolongation.

Effects of reboxetine on sleep and nocturnal cardiac autonomic activity in patients with dysthymia.

Vigabatrin and tiaggabine might have antipanic properties.

Rhabdomyolysis and compartment syndrome with coadministration of risperidone and simvastatin.

The effects of clozapine and high-dose olanzapine on brain function in treatment-resistant schizophrenia: a case study.

Use of reboxetine in bulimia nervosa: a pilot study.

Diabetic keto-acidotic (DKA) coma following olanzapine initiation in a previously euglycaemic woman and successful continued therapy with olanzapine.

Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurons.

Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: comparative study with desipramine, fluvoxamine, venlafaxine and opiates.

The role of α<sub>1</sub>- and α<sub>2</sub>-adrenoreceptors on venlafaxine-induced elevation of extracellular serotonin, noradrenaline and dopamine levels in the rat prefrontal cortex and hippocampus.

Increasing dopaminergic activity: effects of L-dopa and bromocriptine on human sensory gating.

No association between akathisia or Parkinsonism and suicidality in treatment-resistant Schizophrenia.

Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile.

The relationship of sex hormones cortisol with cognitive functioning in schizophrenia.

Cerebral D2 and 5-HT2 receptor occupancy in Schizophrenic patients treated with olanzapine or clozapine.

A positron emission tomography study of the 5-HT<sub>1A</sub> receptor in schizophrenia and during clozapine treatment.

Receptor mechanisms in the treatment of schizophrenia.

Gender differences and the effects of ketamine healthy volunteers.

Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for Psychopharmacology.

An exceptional case of plagiarism!